Previous studies have demonstrated that HIF1α stabilization was adequate to induce an iCAF phenotype and enhance PDAC tumor growth [51], offering a theoretical foundation for the potential differentiation of iCAFs within our comPDAC-FPCL model. The gene discussed is HIF1A; the disease is neoplasm.